Large Desktop
Very Large Desktop

Press archive


altona Diagnostics receives CE-IVD mark for HCV RT-PCR test


Hamburg, February 07, 2019 altona Diagnostics GmbH, today announced the launch of the AltoStar® HCV RT-PCR Kit 1.5, an in vitro diagnostic test, based on real-time RT-PCR technology, for the detection and quantification of hepatitis C virus (HCV) specific RNA (genotypes 1 to 6). Read more


RealStar® Zika Virus RT-PCR Kit 1.0 receives ANVISA approval

altona Diagnostics Brasil LTDA, São Paulo, the Brazilian subsidiary of the German infectious disease specialist altona Diagnostics GmbH (altona), Hamburg, got registration approval of ANVISA for its real-time PCR kit to detect RNA of Zika virus in human sample material.


altona Diagnostics launches CE-IVD marked AltoStar® Molecular Diagnostic Workflow

altona Diagnostics celebrates the launch of the AltoStar® Molecular Diagnostic Workflow.The recently developed CE-IVD marked system will be shown at the ECCMID 2018 which will take place in Madrid, Spain, from 21 - 24 April 2018.


altona Diagnostics’ Cooperation project of MTA training for highly motivated refugees starts in August 2017

Together with our local partners we initiated a new cooperation project to contribute the process of integrating refugees. As first trainee Mustafa Abdulrazak Jadaa starts his medical technical assistant education in August.


altona Diagnostics’ RealStar® Zika Virus RT-PCR Kit 1.0 receives Emergency Use Authorization for Korea

On August 5, 2016, altona Diagnostics GmbH received Emergency Use Authorization (EUA) from the Korea Centers for Disease Control & Prevention (KCDC) for the RealStar® Zika Virus RT-PCR Kit 1.0.